Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ahron Yehonatan Cohen"'
Autor:
Walid Shalata, Rachel Steckbeck, Ilya Polishchuk, Ahron Yehonatan Cohen, Keren Rouvinov, Margarita Tokar, Ashraf Abu Jama, Omar Abu Saleh, Kim Sheva, Alexander Yakobson
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
This case report describes the occurrence of hyperbilirubinemia as a complication of metastatic melanoma. A 72-year-old male patient was diagnosed with BRAF V600E-mutated melanoma with metastases in the liver, lymph nodes, lungs, pancreas, and stomac
Externí odkaz:
https://doaj.org/article/cffe25d51cba484f9b2a30327de7f0da
Autor:
Walid Shalata, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, Abed Agbarya
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2438 (2023)
Immune checkpoint inhibitors have become the standard of care in the treatment of metastatic non-small-cell lung cancer (NSCLC). The combination of nivolumab plus ipilimumab and chemotherapy has been shown to improve outcomes in terms of overall surv
Externí odkaz:
https://doaj.org/article/d217ee7737284174a6a3d089a1e8cd40
Autor:
Walid Shalata, Jeremy Zolnoorian, Gabrielle Migliozzi, Ashraf Abu Jama, Yulia Dudnik, Ahron Yehonatan Cohen, Amichay Meirovitz, Alexander Yakobson
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5938 (2023)
Immune checkpoint inhibitors (ICIs), pembrolizumab in particular, have been shown to be vastly more efficacious than traditional cytotoxic or platinum-based chemotherapies in the treatment of non-small cell lung cancer (NSCLC). While there are plenty
Externí odkaz:
https://doaj.org/article/131f5cc87b61498b9617342595c811c0
Autor:
Moshe Elkabets, Ismaell Massalha, Angel Porgador, Walid Shalata, Ahron Yehonatan Cohen, Vered Fuchs, Baisali Bhattacharya, Alexander Yakobson, Laila C. Roisman, Manu Prasad, Muhammed Iraqi, N. Peled
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3630, p 3630 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3630, p 3630 (2021)
Simple Summary Over the past decades, the multi-drug approach for treating various types of cancers was highly recommended. The aim of this study was to demonstrate the advantage of treating different carcinoma types with several combinations of immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06d1d40f68b5542bdb083358cd291b5
https://doi.org/10.3390/cancers13143630
https://doi.org/10.3390/cancers13143630